FDA Inspection 1038849 — Statline (division of MTF Biologics)
The FDA completed an inspection of Statline (division of MTF Biologics) on January 24, 2018 in Edison, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 24, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Edison, NJ (United States)